The influence of angiotensin-(1-7) Mas receptor agonist (AVE 0991) on mitochondrial proteome in kidneys of apoE knockout mice

被引：18
|
作者：
Suski, Maciej [1 ]
Olszanecki, Rafal [1 ]
Stachowicz, Aneta [1 ]
Madej, Jozef [1 ]
Bujak-Gizycka, Beata [1 ]
Okon, Krzysztof [2 ]
Korbut, Ryszard [1 ]
机构：
[1] Jagiellonian Univ, Coll Med, Chair Pharmacol, PL-31531 Krakow, Poland
[2] Jagiellonian Univ, Coll Med, Chair Pathomorphol, PL-31531 Krakow, Poland
来源：
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS | 2013年 / 1834卷 / 12期
关键词：
Kidney; Mitochondrion; Apolipoprotein E; Angiotensin (1-7); Proteomics; MIGRATION INHIBITORY FACTOR; D-DOPACHROME TAUTOMERASE; CARBONIC-ANHYDRASES; LIVER-MITOCHONDRIA; SYSTEM FOCUS; DISEASE; SUPEROXIDE; METABOLISM; APOPTOSIS; HYPERTENSION;
D O I：
10.1016/j.bbapap.2013.08.008
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Excessive action of angiotensin H on mitochondria has been shown to play an important role in mitochondrial dysfunction, a common feature of atherogenesis and kidney injury. Angiotensin-(1-7)/Mas receptor axis constitutes a countermeasure to the detrimental effects of angiotensin H on AT1 receptors. The aim of the study was to assess the effects of angiotensin-(1-7) peptidomimetic AVE0991 on the kidney mitochondrial proteome in widely used animal model of atherosclerosis (apoE(-/-) mice). Proteins changed in apoE(-/-) mice belonged to the groups of antioxidant enzymes, apoptosis regulators, inflammatory factors and metabolic enzymes. Importantly, AVE0991 partially reversed atherosclerosis-related changes in apoE(-/-) mice. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码：2463 / 2469
页数：7
相关论文
共 50 条
  • [1] The nonpeptide AVE 0991 is an agonist for the angiotensin-(1-7) receptor Mas in the mouse kidney
    Sampaio, W
    Machado, L
    Mendes, E
    Walther, T
    Santos, R
    JOURNAL OF HYPERTENSION, 2004, 22 : S177 - S177
  • [2] Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney
    Pinheiro, SVB
    Silva, ACSE
    Sampaio, WO
    de Paula, RD
    Mendes, EP
    Bontempo, ED
    Pesquero, JB
    Walther, T
    Alenina, N
    Bader, M
    Bleich, M
    Santos, RAS
    HYPERTENSION, 2004, 44 (04) : 490 - 496
  • [3] Influence of angiotensin-(1-7) peptidemimetic (AVE 0991) on liver mitoproteome in apoE-knockout mice
    Suski, Maciej
    Olszanecki, Rafal
    Bujak-Gizycka, Beata
    Madej, Jozef
    Stachowicz, Aneta
    Korbut, Ryszard
    VASCULAR PHARMACOLOGY, 2012, 56 (5-6) : 384 - 384
  • [4] AVE 0991-ANGIOTENSIN-(1-7) RECEPTOR AGONIST, INHIBITS ATHEROGENESIS IN APOE-KNOCKOUT MICE
    Toton-Zuranska, J.
    Gajda, M.
    Pyka-Fosciak, G.
    Kus, K.
    Pawlowska, M.
    Niepsuj, A.
    Wolkow, P.
    Olszanecki, R.
    Jawien, J.
    Korbut, R.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2010, 61 (02): : 181 - 183
  • [5] THE INFLUENCE OF ANGIOTENSIN-(1-7) PEPTIDOMIMETIC (AVE 0991) AND NEBIVOLOL ON ANGIOTENSIN I METABOLISM IN AORTA OF apoE-KNOCKOUT MICE
    Olszanecki, R.
    Suski, M.
    Gebska, A.
    Toton-Zuranska, J.
    Kus, K.
    Madej, J.
    Bujak-Gizycka, B.
    Jawien, J.
    Korbut, R.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2013, 64 (03): : 317 - 320
  • [6] Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonist
    Santos, Robson A. S.
    Ferreira, Anderson J.
    CARDIOVASCULAR DRUG REVIEWS, 2006, 24 (3-4): : 239 - 246
  • [7] ANGIOTENSIN-(1-7) RECEPTOR Mas AGONIST AMELIORATES PROGRESS OF ATHEROSCLEROSIS IN apoE-KNOCKOUT MICE
    Jawien, J.
    Toton-Zuranska, J.
    Gajda, M.
    Niepsuj, A.
    Gebska, A.
    Kus, K.
    Suski, M.
    Pyka-Fosciak, G.
    Nowak, B.
    Guzik, T. J.
    Marcinkiewicz, J.
    Olszanecki, R.
    Korbut, R.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2012, 63 (01): : 77 - 85
  • [8] Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice
    Justyna Totoń-Żurańska
    Jacek Jawień
    Rafał Olszanecki
    Ryszard Korbut
    Pharmacological Reports, 2013, 65 (Suppl 1) : 94 - 94
  • [9] Effect of AVE 0991 angiotensin-(1-7) receptor agonist treatment on elemental and biomolecular content and distribution in atherosclerotic plaques of apoE-knockout mice
    Kowalska, J.
    Gajda, M.
    Jawien, J.
    Kwiatek, W. M.
    Appel, K.
    Dumas, P.
    RADIATION PHYSICS AND CHEMISTRY, 2013, 93 : 142 - 149
  • [10] The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats
    Ebermann, Linda
    Spillmann, Frank
    Sidiropoulos, Melanie
    Escher, Felicitas
    Heringer-Walther, Silvia
    Schultheiss, Heinz-Peter
    Tschoepe, Carsten
    Walther, Thomas
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 590 (1-3) : 276 - 280
12345